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Background: Staphylococcus aureus (S. aureus) small colony variants (SCVs) can
survive within the host intracellular milieu and are associated with chronic relapsing
infections. However, it is unknown whether host invasion rates and immune responses
differ between SCVs and their wild-type counterparts. This study used a stable
S. aureus SCV (WCH-SK2SCV) developed from a clinical isolate (WCH-SK2WT)
in inflammation-relevant conditions. Intracellular infection rates as well as host
immune responses to WCH-SK2WT and WCH-SK2SCV infections were investigated.
Method: NuLi-1 cells were infected with either WCH-SK2WT or WCH-SK2SCV, and
the intracellular infection rate was determined over time. mRNA expression of cells
infected with each strain intra- and extra-cellularly was analyzed using a microfluidic
qPCR array to generate an expression profile of thirty-nine genes involved in the host
immune response.
Results: No difference was found in the intracellular infection rate betweenWCH-SK2WT
and WCH-SK2SCV. Whereas, extracellular infection induced a robust pro-inflammatory
response, intracellular infection elicited a modest response. Intracellular WCH-SK2WT
infection induced mRNA expression of TLR2, pro-inflammatory cytokines (IL1B, IL6,
and IL12) and tissue remodeling factors (MMP9). In contrast, intracellular WCH-SK2SCV
infection induced up regulation of only TLR2.
Conclusions: Whereas, host intracellular infection rates of WCH-SK2SCV and
WCH-SK2WT were similar, WCH-SK2SCV intracellular infection induced a less widespread
up regulation of pro-inflammatory and tissue remodeling factors in comparison to
intracellular WCH-SK2WT infection. These findings support the current view that SCVs
are able to evade host immune detection to allow their own survival.
Keywords: Staphylococcus aureus, small colony variant, innate immune response, epithelial cells, tissue
remodeling
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INTRODUCTION
Staphylococcus aureus (S. aureus) is a common pathogen known
to have the ability to adapt to different host environments. Some
S. aureus strains are capable of switching to an alternative Small
Colony Variant (SCV) phenotype, allowing their survival under
stressful conditions (Proctor et al., 2006; Bui et al., 2015b). S.
aureus SCVs have been identified for many decades (Jensen,
1957), but only sparked more research interest in recent years
when they were found to be associated with chronic recurrent
infections in both humans (Schneider et al., 2008; Maduka-Ezeh
et al., 2012; Wolter et al., 2013; Tande et al., 2014; Masoud-
Landgraf et al., 2016) and animals (Atalla et al., 2008; Alkasir
et al., 2013).
Generally, the model is that SCVs are auxotrophic to haemin
(Kohler et al., 2003; Seggewiss et al., 2006; Von Eiff et al., 2006),
menadione (Von Eiff et al., 2006) or thymidine (Chatterjee et al.,
2007; Maduka-Ezeh et al., 2012) leading to defects in energy
production and tricarboxylic acid metabolism and hence their
slower growth and smaller colony size (Proctor et al., 2006).
SCVs also show reduced hemolysis, loss of pigmentation, and
increased tolerance of antibiotics (Proctor et al., 1994). These
features make the detection and treatment of SCVs challenging
in the clinical setting.
S. aureus has been found to have the ability to invade
mammalian cells (Clement et al., 2005). Different reports show
that upon invasion of mammalian cells, S. aureus can switch to
a SCV phenotype and thereby be better adapted to the hostile
intracellular environment than the parental, non-SCV cell type
(henceforth referred to as wild type) (Tuchscherr et al., 2011;
Tan et al., 2014). Once inside the cell, S. aureus SCVs have
been shown to switch off their toxin production enabling them
to survive in the host for prolonged periods of time without
inducing an immune response (Tan et al., 2014; Ou et al., 2016).
The switch from wild type to SCV is therefore strongly associated
with improved survival within the host and defense against
the antimicrobial processes; antibiotics and host immune cells
(Tuchscherr et al., 2010).
SCVs’ detection and identification are not only challenging
in the clinical situation. Their accurate study in the laboratory
setting is also problematic as clinical SCV isolates are often
highly unstable and can rapidly revert to the wild type
phenotype. Therefore, the majority of studies conducted on
SCVs use laboratory-generated mutant S. aureus strains rather
than naturally derived SCVs (Kohler et al., 2003; Seggewiss
et al., 2006). In a recent study, Bui et al. simulated the
inflammatory environment by adding different concentrations
of organic chemicals relevant to the host immune response
(i.e., methylglyoxal) together with low nutrients and bacterial
growth rate for a prolonged timeframe (Bui et al., 2015a,b).
After 50 days of continuous incubation in these conditions
of one particular S. aureus clinical strain, WCH-SK2WT,
the bacterial population included an increased number
(80% of the colonies) of stable SCVs (Bui et al., 2015a).
This provides a valuable resource of a clinical isolate in
a parental form and then in an experimentally useable
SCV state.
Epithelial cells lining mucosal layers such as sinonasal and
intestinal mucosa form an important physical barrier between
hosts and the outside world. This mucosal surface is part of
the first line innate defense as this is the site where pathogens
interface with hosts. Previous in vitro studies have shown that
epithelial cells infected with wild type S. aureus had increased
expression of cytokines/chemokines including interleukin (IL)6
(Damm et al., 2006; Sachse et al., 2010), CXCL8 (Damm et al.,
2006; Kohanski and Lane, 2015) and tumor necrosis factor (TNF)
(Li et al., 2009; Kohanski and Lane, 2015) and tissue remodeling
factors such as matrix metalloproteinases (MMPs) (Homma
et al., 2015). An in vitro study by Tuchscherr et al. showed
increased expression of C-C motif chemokine ligand (CCL) 5, C-
X-C motif ligand (CXCL) 10 and 11, and intracellular adhesion
molecule (ICAM)1 when endothelial cells were infected with wild
type S. aureus but not S. aureus SCVs (Tuchscherr et al., 2010).
Whilst these studies invariably showed an induction of a host
immune response upon S. aureus infection in vitro, there was
no differentiation between the host immune response induced
by extracellular vs. intracellular S. aureus. The aim of this study
was to identify whether there is a difference in the intracellular
infection rate of airway epithelial cells betweenWCH-SK2WT and
WCH-SK2SCV as well as the cellular immune response that they
induce 24 h after internalization.
MATERIALS AND METHODS
Ethics
Ethics approval for this study was granted by the Human
Research Ethics Committee of The Queen Elizabeth Hospital
(South Australia, Australia).
Bacterial Strains
S. aureus WCH-SK2 wild type (WCH-SK2WT) is a clinically
isolated strain in blood culture from a patient with sepsis. This
wild type parental strain was found to have increasing number
of stable SCVs after prolonged culture under nutrient poor
environment (Bui et al., 2015a). The frozen stocks of WCH-
SK2WT and WCH-SK2 Day50 (D50) were kindly donated by
SK (University of Adelaide). A population of stable SCVs from
WCH-SK2 D50 were isolated, termed WCH-SK2SCV, and used
in the subsequent infection experiments. Both WCH-SK2WT
and WCH-SK2SCV strains were cultured on brain heart infusion
(BHI) agar at 37◦C for 24 h (Figure 1). A single colony from each
strain was then cultured in BHI broth at 37◦C overnight with
agitation.
Eukaryotic Cell Culture
The human bronchial epithelial cell line, NuLi-1 (CRL-4011),
was chosen for the following intracellular infection experiments
and gene expression study as NuLi-1 cells have been shown
to possess conserved TLR gene expression and innate immune
response pathways when compared to primary human airway
epithelial cells (Cooksley et al., 2015). The cells were purchased
from ATCC and cultured in bronchial epithelial growth medium,
BEGM (CC-3170, Lonza, Switzerland) supplemented with G-418
at 50 µg/ml. The cells were cultured in collagen (04902, Stemcell
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FIGURE 1 | WCH-SK2WT and WCH-SK2SCV colony. Culture of S. aureus
WCH-SK2WT (left) and WCH-SK2SCV (right) on brain heart infusion agar at
37◦C for 24 h. WCH-SK2WT = Staphylococcus aureus WCH-SK2 strain wild
type, WCH-SK2SCV = Staphylococcus aureus WCH-SK2 strain small colony
variant.
Technologies, Canada) coated T75 flasks. Passage 4 and 5 cells
were used for all S. aureus infections.
S. aureus Intracellular Infection
Optimization
NuLi-1 cells were seeded onto collagen coated 8-chamber culture
slides (FAL354108, Corning, USA) at 1.6 × 105 cells/ml for
24 h prior to S. aureus infection. Overnight BHI broth culture
of S. aureus WCH-SK2WT and WCH-SK2SCV were centrifuged
at 3080 × g for 10min at room temperature and pellets were
resuspended in 0.9% saline and made up to McFarland Unit
(MFU) 2, 3, and 4 standards. The bacterial solution was diluted
1:12.5 in BEGM (which was equivalent to MOI 50, 100, and 150
respectively) and incubated with NuLi-1 cells for 1, 2, 3, 4, 6,
and 8 h at 37◦C with 5% CO2 and 90% humidity. The medium
containing bacteria was removed at the end of the incubation and
the cells were washed twice using PBS buffer. Lysostaphin (L7386,
Sigma-Aldrich, USA) was then added to the medium at 4 µg/ml
for 30 min to lyse any remaining extracellular S. aureus. The
cell culture continued for another 24 h with gentamycin (15750-
060, Gibco Fisher Scientific International, USA) at 100 µg/ml.
After 24 h the cells were fixed using methanol for 7 min. NuLi-1
cells were stained using Giemsa stain for 1 h and the slides were
examined using a light microscope (Eclipse 90i, Nikon, Japan) at
100X magnification with immersion oil. Minimally 200 NuLi-1
cells were counted from each well to determine the intracellular
infection rate (Figure 2). Lactate dehydrogenase (LDH) assays
were performed using cell supernatants to determine cell viability
as per the manufacturer’s instruction (G1780, Promega, USA).
Cell viability was calculated in reference to NuLi-1 cells at time
0 prior to any treatment. Three separate experiments in duplicate
were performed.
S. aureus Infection for Gene Expression
Analysis
NuLi-1 cells were seeded into 12-well plates (PIMWS1250, EMD
Millipore, USA) as per 8-chamber culture slides. There were two
arms of treatment- extracellular vs. intracellular infections. For
FIGURE 2 | NuLi-1 cells with intracellular S. aureus. NuLi-1 cells were
incubated with S. aureus for 6 h, followed by lysostaphin treatment. The cells
were fixed using methanol and stained by Giemsa stain. The cells were
examined using a light microscope at 100X magnification with immersion oil.
S. aureus was stained dark purple within the cytoplasm.
each arm the cells were treated with either no bacteria (negative
controls), S. aureusWCH-SK2WT (MOI 100) or S. aureusWCH-
SK2SCV (MOI 100). For extracellular infections, S. aureus was
added to BEGM for the entire 24 h of incubation without
lysostaphin or gentamycin treatment. The intracellular infection
protocol was as per the intracellular optimization experiment.
S. aureus solution in BEGM (MOI 100) was added to the cells
for 6 h incubation followed by 30min of lysostaphin treatment
and 17.5 h of incubation with gentamycin added to BEGM. Four
independent experiments with triplicates within each treatment
were performed.
RNA Extraction and Real-Time Polymerase
Chain Reaction (PCR)
NuLi-1 cells were lysed at 24 h using 350 µl buffer RLT (79216,
Qiagen, Germany) containing 3.5µl 2-mercaptoethanol (M3148,
Sigma-Aldrich, USA) per well. RNA extraction was performed
using RNeasy Mini Kit (74106, Qiagen, Germany) as per the
manufacturer’s instructions. Thirty-nine genes (Supplementary
Table 1) involved in innate and adaptive immune response as
well as tissue remodeling were selected for gene expression
analysis. Quantitect Reverse Transcription Kit (205313, Qiagen,
Germany) was used for cDNA synthesis as per the manufacturer’s
instructions. The cDNA was pre-amplified with the 39-pooled
Taqman gene expression assays for 16 cycles of 95◦C for 15 s
and 60◦C for 4 min. The pre-amplified cDNA was diluted 1:5
in DNA Suspension Buffer (T0221, TEKnova Inc, CA, USA).
Samples were prepared using 2.25 µl diluted cDNA, 2.5 µl
2X Master Mix and 0.25 µl 20X GE Sample Loading Reagent
(85000746, Fluidigm Corporation, CA, USA). Gene assays were
prepared by mixing 2.5 µl 20X Taqman Gene Expression Assays
with 2.5 µl 2X Assay Loading Reagent (85000746, Fluidigm
Corporation, CA, USA). Both samples and assays were loaded
on to a 48.48 Dynamic Array chip (BMK-M-48.48, Fluidigm
Corporation, CA, USA) and primed into the matrix using IFC
Controller MX (Fluidigm Corporation, CA, USA). Real-time
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PCR was conducted using Biomark HD Platform (Fluidigm
Corporation, CA, USA) and programmed as follows: 95◦C for
1 min and 35 cycles of 96◦C for 5 s and 60◦C for 20 s.
Data acquisition and analysis was performed using Fluidigm
Real-Time PCR Analysis Software v4.1.2 (Fluidigm Corporation,
CA, USA). Delta-cycle threshold (1Ct) values were calculated in
reference to the hypoxanthine phophoribosyltransferase (HPRT)
1 housekeeping gene. Delta-1Ct (11Ct) values were calculated
in reference to negative control cells and all data was presented as
fold change (2−11Ct).
Statistical Analysis
Statistical analysis was performed using IBM SPSS Statistics,
Version 23.0 (IBM Corp., Armonk, NY, USA). Kruskal–Wallis
test was used to compare the intracellular infection of S. aureus of
different MOI and incubation time as well as cell viability post S.
aureus infection. A two-tailed t-test with permutation was used
to analyse the relative gene expression fold changes for WCH-
SK2WT and WCH-SK2SCV in comparison to negative control
cells. Statistical significance was defined as p< 0.05.
RESULTS
Comparison of Intracellular Infection Rate
of WCH-SK2WT and WCH-SK2SCV
The intracellular infection rate was found to increase with
increasing bacterial incubation times with NuLi-1 cells for both
WCH-SK2WT andWCH-SK2SCV. As shown in Figures 3A,B, for
both WCH-SK2WT and WCH-SK2SCV strains, the intracellular
infection rate of NuLi-1 cells was less than 30% after 1
or 2 h incubation, and increased significantly after 4 h (41–
44%, p ≤ 0.001) and 6 h (58–63%, p ≤ 0.001) incubation.
Longer incubation times of up to 8 h did not further improve
infection rates which remained at around 60%. There was
no difference found in intracellular infection rate of NuLi-1
cells between WCH-SK2WT and WCH-SK2SCV. Furthermore,
when comparing different concentrations of bacteria, there
was no difference found; using MOI 50, 100, and 150 at the
same given incubation time. Overall, the time of bacterial
incubation with NuLi-1 cells was found to be a more important
factor to increase intracellular infection rate than bacterial
concentration.
FIGURE 3 | WCH-SK2WT and WCH-SK2SCV intracellular infection rate and cell viability post infection. Comparison of intracellular infection rate in NuLi-1
cells between S. aureus WCH-SK2WT (A) and WCH-SK2SCV (B) strains (MOI 100). NuLi-1 cells were incubated with either WCH-SK2WT and WCH-SK2SCV for a
variable incubation time. The cells were treated with lysostaphin to remove any extracellular S. aureus and the incubation was continued with gentamycin. The
intracellular infection rate was determined 24 h post lysostaphin treatment. The data shown is mean ± SD of three independent experiments measured. **p ≤ 0.01,
***p ≤ 0.001, ****p ≤ 0.0001, Kruskal–Wallis test. NuLi-1 cell viability post extracellular and intracellular S. aureus infection was determined using an LDH assay
(C). For extracellular infections, the S. aureus was incubated with the cells for 24 h. For intracellular infections, the S. aureus was incubated with the cells for 6 h
followed by lysostaphin treatment. The cells were incubated with gentamycin for another 17.5 h for a total of 24 h of incubation respectively. The data shown is mean
± SD of three independent experiments measured. Kruskal–Wallis test. LDH = Lactate dehydrogenase, WCH-SK2WT = Staphylococcus aureus strain WCH-SK2
wild type. WCH-SK2SCV = Staphylococcus aureus strain WCH-SK2 small colony variant.
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Host Cell Viability during S. aureus
Infection
LDH cell toxicity assays showed the absence of significant toxicity
for both WCH-SK2WT and WCH-SK2SCV extracellular and
intracellular infection of NuLi-1 cells compared to control cells
for 24 h (p > 0.05). The viability was greater than 75% for
extracellular bacterial challenge and was greater than 90% for
intracellular infection of NuLi-1 cells with WCH-SK2WT and
WCH-SK2SCV for 24 h (Figure 3C).
Differential Gene Expression Profiles of
Infected Cells
Gene expression was normalized to the housekeeping gene
HPRT1 and compared between negative controls and cells
exposed to different bacterial challenges. A total of thirty-nine
genes were tested. Seven of these genes, CCL11, IL10, IL17A,
IL25, interferon gamma (INFG), toll like receptor (TLR) 1, and
TNF were not expressed in any of the samples. Three genes,
IL33, lymphotoxin alpha (LTA), and NLR family pyrin domain
containing 3 (NLRP3) were expressed at a very low levels in a few
samples only and undetectable in the remaining samples.
The Influence of S. aureusWCH-SK2WT
and WCH-SK2SCV Intracellular Infection
Differential gene expression in WCH-SK2WT intracellularly
infected cells in comparison to negative control cells at 24 h is
summarized in Supplementary Table 2. Up regulation was found
for IL1B (fold change 2.62, p = 0.04), IL6 (fold change 4.27, p =
0.04), IL12 (fold change 1.84, p= 0.04),MMP9 (fold change 4.88,
p = 0.04) and TLR2 (fold change 2.45, p = 0.04) in NuLi-1 cells
infected with intracellular WCH-SK2WT (Figure 4).
FIGURE 4 | mRNA gene expression changes in NuLi-1 cells at 24h of
WCH-SK2WT and WCH-SK2SCV intracellular infection. The cells were
incubated with S. aureus for 6 h (MOI 100), followed by lysostaphin treatment.
The cells were incubated with gentamycin for another 17.5 h prior cell lysis
and RNA extraction. The values represent the mean ± SD of four independent
experiments measured. *p ≤ 0.05, n.s. = non-significant, two tailed t-test with
permutation between either WCH-SK2WT or WCH-SK2SCV vs. negative
controls. WCH-SK2WT = Staphylococcus aureus strain WCH-SK2 wild type.
WCH-SK2SCV = Staphylococcus aureus strain WCH-SK2 small colony
variant.
The same comparison was made between WCH-SK2SCV
intracellularly infected cells and negative controls cells at 24 h
(Figure 4). Up regulation was only found for TLR2 (fold change
3.12, p = 0.04). Overall, there was less widespread immune




Up regulation of CSF2 (fold change 492.1, p= 0.05), CXCL8 (fold
change 29.10, p = 0.05), fibronectin (FN) 1 (fold change 1.67,
p = 0.05), MMP1 (fold change 13.90, p = 0.05), MMP9 (fold
change 17.89, p= 0.05) andMMP10 (fold change 6.58, p= 0.05)
was found in cells infected with WCH-SK2WT extracellularly
for 24 h in comparison to negative controls (Figure 5). On
the other hand, transforming growth factor beta (TGFB) 2 was
down regulated (fold change 0.26, p = 0.05) in WCH-SK2WT
infected cells.
CSF2 (fold change 97.01, p= 0.04), CXCL8 (fold change 35.34,
p = 0.04, IL6 (fold change 14.12, p = 0.04), MMP1 (fold change
8.53, p = 0.04), MMP9 (fold change 8.81, p = 0.04) and TLR2
(fold change 3.81, p = 0.04) were significantly up regulated in
NuLi-1 cells infected with WCH-SK2SCV extracellularly for 24 h
(Figure 5). Details of all the changes in gene expression in cells
withWCH-SK2WT andWCH-SK2SCV extracellular infection has
been included in Supplementary Table 3.
The Influence on Gene Expression by
Extracellular vs. Intracellular Infection
In WCH-SK2SCV infected cells, CXCL8 (fold change 35.34 vs.
3.55 for extracellular and intracellular infection respectively,
p = 0.04), and IL6 (fold change 14.12 vs. 5.05 for extracellular
and intracellular infection respectively, p = 0.04) expression was
FIGURE 5 | mRNA gene expression changes in NuLi-1 cells at 24 h of
WCH-SK2WT and WCH-SK2SCV extracellular infection. The cells were
incubated with S. aureus for 24 h (MOI 100), followed by cell lysis and RNA
extraction. The values represent the mean ± SD of four independent
experiments measured. *p ≤ 0.05, n.s. = non-significant, 2 tailed t-test with
permutation between either WCH-SK2WT or WCH-SK2SCV vs. negative
controls. WCH-SK2WT = Staphylococcus aureus strain WCH-SK2 wild type.
WCH-SK2SCV = Staphylococcus aureus strain WCH-SK2 small colony
variant.
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FIGURE 6 | mRNA gene expression changes in NuLi-1 cells at 24h of
WCH-SK2SCV extracellular vs. intracellular infection. The cells were
incubated with S. aureus for either 24 h (extracellular infection) or 6 h
(intracellular infection) followed by lysostaphin treatment and 17.5 h of
incubation with gentamycin. The values represent the mean ± SD of four
independent experiments measured. *p ≤ 0.05, two tailed t-test with
permutation between WCH-SK2SCV extracellular and intracellular infections.
WCH-SK2SCV = Staphylococcus aureus strain WCH-SK2 small colony
variant.
significantly higher in extracellular than intracellular infected
cells (Figure 6).
When comparing extracellular vs. intracellular infection of
WCH-SK2WT, there was no significant difference found in gene
expression for any of the genes tested.
DISCUSSION
This study was conducted to evaluate the differences between
a clinically isolated S. aureus strain, WCH-SK2WT, and its
laboratory derived SCV strain, WCH-SK2SCV, in terms of their
ability to invade epithelial cells as well as the subsequent host
cellular response they elicit. Extracellular S. aureus infection
with both WCH-SK2WT and WCH-SK2SCV induced a similar
up regulation of innate immune cytokines/chemokines (e.g.,
CXCL8 and IL1B) as well as tissue remodeling genes (e.g.,
MMP9) within 24 h. With intracellular S. aureus infection,
while the pattern of gene expression change was similar between
both variants, WCH-SK2WT induced a more widespread innate
immune response than WCH-SK2SCV.
Adherence of S. aureus to host cells is the first vital step
for host intracellular invasion. S. aureus fibronectin-binding
proteins (FnBPs) are a group of the adhesins that have been
most widely studied. It has been shown that binding of FnBPs
to host fibronectin leads to activation of integrin mediated
signaling pathways, reorganization of the actin cytoskeleton,
and internalization of S. aureus (Agerer et al., 2005; Selbach
and Backert, 2005; Schroder et al., 2006). S. aureus lacking
FnBPs were found to have a significantly reduced internalization
rate in bovine epithelial cells and in a mouse mastitis model
(Brouillette et al., 2003a,b). ECM-binding protein homolog (Ebh)
is a 1.1-megadalton S. aureus protein that binds to fibronectin,
and was previously found to be significantly up regulated in
WCH-SK2SCV (log2 5.3 fold) in comparison to WCH-SK2
WT
(Bui et al., 2015a). Despite this up regulation and the notion that
S. aureus isolated from within host cells are frequently SCVs (Tan
et al., 2014) and can survive within the intracellular environment
(Tuchscherr et al., 2010), no increase in intracellular infection
rate of WCH-SK2SCV compared to WCH-SK2WT was found in
our study. This finding is in line with other reports that failed
to show an alteration in virulence of ebh mutant strains (Clarke
et al., 2002) and indicates that the Ebh protein is not critical for
intracellular invasion of S. aureus. Also, it has been shown that
only some SCV strains have increased infection rates compared
to their wild-type counterparts and that both the mammalian cell
type and SCV strain can influence infection rate and survival of
SCVs within the host (Tuchscherr et al., 2010).
TLRs are transmembrane proteins that recognize pathogen
associated-molecular patterns (PAMPs) and play a crucial role
in innate immune responses. TLR2 is the main receptor for
S. aureus recognition (Zahringer et al., 2008). In our study,
TLR2 (but not TLR6) was found to be up regulated in
both S. aureus WCH-SK2WT and WCH-SK2SCV infection (i.e.,
intracellular WCH-SK2WT and WCH-SK2SCV, and extracellular
WCH-SK2SCV infection). TLR2 forms heterodimers with TLR1
or TLR6 to bind to either di-acylated (TLR2/TLR6 heterodimers)
or tri-acylated lipopeptides (TLR2/TLR1 heterodimer) (Jin et al.,
2007) and are involved in S. aureus peptidoglycan recognition in
macrophages (Ozinsky et al., 2000; Nishiya and Defranco, 2004).
A relative increase of TLR2 expression in airway epithelial cells
has been shown to augment the innate immune response of these
cells to further TLR2 agonists, as can be expected (Melkamu
et al., 2009). Previous research has also shown that signaling
through the TLR2/TLR6 heterodimer induced by S. aureus can
induce IL10 production and apoptosis of antigen-presenting
cells and is used by the bacteria to evade the immune response
initiated by its own exotoxins (Takeda and Akira, 2005; Chau
et al., 2009). Whether the increased TLR2 expression in S. aureus
infected airway epithelial cells translates to an altered sensitivity
of these cells to specific microbial triggers and how this affects the
immune response to itself and to different microbial organisms is
unclear and warrants further investigation.
In our study, in comparison to intracellular infection, which
induced a modest pro-inflammatory response as reported by
others (Tuchscherr et al., 2011; Tan et al., 2014), extracellular
infection induced manifest changes in gene expression of pro-
immune factors (such as CSF2, CXCL8) and of tissue remodeling
factors (such as MMP1, MMP9) as expected (Wang et al., 2010).
The combined effect of these factors is hypothesized to enhance
a Th1-type immune response facilitating neutrophil recruitment
(Van Den Steen et al., 2000).
Intracellular infection with the S. aureus WCH-SK2WT
elicited a more consistent innate immune response in
comparison to intracellular S. aureus WCH-SK2SCV infection
with an increased expression of IL1B, IL6, IL12, MMP9, and
TLR2 at 24 h. In contrast, intracellular WCH-SK2SCV infection
only induced up regulation of TLR2 but not any significant
cytokines expression after 24 h of infection. This data indicates
that while the wild type S. aureus was able to invade NuLi-1 cells,
it elicited a more widespread innate response which can lead to
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earlier host elimination. This finding is consistent with a study
conducted by von Eiff et al. in which they showed that wild type
S. aureus was able to invade host cells but did not survive as long
as SCVs within the intracellular environment (Von Eiff et al.,
2001).
S. aureus has been shown to induce the tissue remodeling
factors MMP2, MMP9, and TIMP1 in mucosal explants from
chronic rhinosinusitis (CRS) patients (Wang et al., 2010).
Similarly, we also found an up regulation of tissue remodeling
factors induced by extracellular infection with WCH-SK2WT
(MMP1, MMP2, and MMP10) and WCH-SK2SCV (MMP1 and
MMP9) as well as intracellular infection with WCH-SK2WT
(MMP9). The exact mechanism of how S. aureus induces tissue
remodeling is not fully understood. A study conducted by Pender
and Macdonald has shown that S. aureus enterotoxin B was
associated with up regulation of MMPs in fetal mesenchymal
cells (Pender and Macdonald, 1998). WCH-SK2WT and WCH-
SK2SCV are known to produce enterotoxin A, K, and L
when cultured in liquid broth (unpublished data) (Bui et al.,
2015a). Interestingly, in our experiments, MMP9 up regulation
was significantly higher in extracellular WCH-SK2WT infection
compared to intracellular WCH-SK2WT infection and MMP9
was not significantly induced by intracellular infection with
the WCH-SK2SCV variant. This finding could be explained by
previous research that showed that some S. aureus strains can
switch off or reduce their enterotoxin production upon host cell
invasion and SCV formation (Tan et al., 2014). It is also known
that TGFB can modify the expression, secretion, and activation
of MMPs, which can reciprocally activate latent TGFB affecting
the balance of ECM remodeling (Krstic and Santibanez, 2014).
Our results, however, show a down regulation of TGFB2 and up
regulation of MMPs in NuLi-1 cells infected with extracellular
WCH-SK2WT, potentially indicating a negative feedback loop.
Further research is needed to determine the molecular entities
and pathways activated that determine the increased expression
of MMP9 by epithelial cells upon encounter with S. aureus.
Since we aimed to compare gene expression changes between
different bacterial strains, and for reasons of feasibility and
reproducibility, in our study, we used a normal bronchial
epithelial cell line (NuLi-1 cells) rather than primary nasal
epithelial cells (HNECs). Previous studies have indeed confirmed
these cells to respond to different TLR agonists, confirming their
capacity to respond to microbial stimulations (Cooksley et al.,
2015). Some differences in the extent of their innate immune
response to some TLR agonists when compared to HNECs
have been observed however (Cooksley et al., 2015). These
differences could be due to the fact that NuLi-1 cells have been
transformed and are of bronchial origin, compared to HNECs,
which are derived from the nasal mucosa. Further experiments
using primary cell cultures should therefore be conducted to
confirm the specific individual gene expression changes induced
by different S. aureus strains.
CONCLUSION
Our study demonstrated that the WCH-SK2SCV strain did not
have increased intracellular infection rate in comparison to its
wild type parent strain, WCH-SK2WT. While both WCH-SK2WT
and WCH-SK2SCV were able to invade and reside within NuLi-
1 cells, the innate immune response to WCH-SK2WT was more
robust compared to the response elicited by WCH-SK2SCV.
This provides further evidence supporting the notion that S.
aureus SCVs are better equipped to evade immune detection and
elimination by host cell.
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